CN Patent

CN104027306A — 帕罗西汀口服混悬液及其制备方法

Assigned to BEIJING D-VENTUREPHARM TECHNOLOGY DEVELOPMENT Co Ltd · Expires 2014-09-10 · 12y expired

What this patent protects

本发明是一种包含帕罗西汀（Paroxetine）及其盐的药物树脂盐的口服混悬溶液，是一种抗抑郁剂，其性质稳定且具有良好口感。

USPTO Abstract

本发明是一种包含帕罗西汀（Paroxetine）及其盐的药物树脂盐的口服混悬溶液，是一种抗抑郁剂，其性质稳定且具有良好口感。

Drugs covered by this patent

Patent Metadata

Patent number: CN104027306A
Jurisdiction: CN
Classification: —
Expires: 2014-09-10
Drug substance claim: No
Drug product claim: No
Assignee: BEIJING D-VENTUREPHARM TECHNOLOGY DEVELOPMENT Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.